carbidopa and raclopride

carbidopa has been researched along with raclopride in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calne, DB; Doudet, D; Hewitt, KA; Nugent, R; Olanow, W; Pate, BD; Perl, DP; Shinotoh, H; Snow, BJ1
Andrén, PE; Ekesbo, A; Gunne, LM; Tedroff, J1
Ahier, RG; Ashworth, S; Hume, SP; Opacka-Juffry, J1
Brousolle, E; Dentresangle, C; Froment, JC; Guerin, J; Lavenne, F; Le Bars, D; Pierre, C; Pollak, P; Veyre, L1
Hamann, M; Lange, N; Richter, A; Shashidharan, P1
Abi-Dargham, A; Bailey, V; Brown, PJ; Chen, C; Roose, SP; Rutherford, BR; Slifstein, M; Stern, Y; Valente, E; Vanegas-Arroyave, N; Wall, MW1

Trials

1 trial(s) available for carbidopa and raclopride

ArticleYear
Effects of L-DOPA Monotherapy on Psychomotor Speed and [
    Biological psychiatry, 2019, 08-01, Volume: 86, Issue:3

    Topics: Aged; Aged, 80 and over; Carbidopa; Corpus Striatum; Depressive Disorder, Major; Dopamine; Dopamine Antagonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; New York; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Walking Speed

2019

Other Studies

5 other study(ies) available for carbidopa and raclopride

ArticleYear
MRI and PET studies of manganese-intoxicated monkeys.
    Neurology, 1995, Volume: 45, Issue:6

    Topics: Animals; Carbidopa; Corpus Striatum; Deoxyglucose; Drug Therapy, Combination; Dystonia; Fluorodeoxyglucose F18; Globus Pallidus; Glucose; Levodopa; Macaca mulatta; Magnetic Resonance Imaging; Male; Manganese Poisoning; Parkinson Disease, Secondary; Raclopride; Salicylamides; Substantia Nigra; Tomography, Emission-Computed

1995
(-)-OSU 6162 inhibits levodopa-induced dyskinesias in a monkey model of Parkinson's disease.
    Neuroreport, 1997, Jul-28, Volume: 8, Issue:11

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Callithrix; Carbidopa; Dopamine Antagonists; Levodopa; Male; Motor Activity; Parkinson Disease, Secondary; Piperidines; Posture; Raclopride; Salicylamides

1997
Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET.
    Journal of neural transmission (Vienna, Austria : 1996), 1998, Volume: 105, Issue:4-5

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dopamine; Enzyme Inhibitors; gamma-Aminobutyric Acid; Globus Pallidus; Hydrazines; Kinetics; Levodopa; Male; Microdialysis; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Time Factors; Tomography, Emission-Computed

1998
Striatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:6

    Topics: Adult; Aged; Antiparkinson Agents; Brain Mapping; Carbidopa; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Drug Combinations; Female; Fluorine Radioisotopes; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Raclopride; Receptors, Dopamine D2; Tomography, Emission-Computed

1999
Behavioural and pharmacological examinations in a transgenic mouse model of early-onset torsion dystonia.
    Pharmacology, biochemistry, and behavior, 2011, Volume: 97, Issue:4

    Topics: Amphetamines; Animals; Anxiety; Behavior, Animal; Carbidopa; Chromans; Disease Models, Animal; Dystonia; Levodopa; Locomotion; Mice; Mice, Transgenic; Quinpirole; Raclopride

2011